ARCHIVED AUGUST 2018. Collaborative Insulin Baseline Audit in NHS Trusts

· Medicines Use and Safety Team

A collaborative insulin baseline audit was undertaken in 2010 by the Clinical Directorate of the East and South East England Specialist Pharmacy Services. 54 NHS trusts contributed to the audit of 1,602 patients on insulin therapy. 957 prescribing safety incidents were identified by ward pharmacy staff; the most common types were wrong/unclear administration device (50%), wrong/unclear dose or strength (23%), omitted from prescription (9%) and wrong/unclear product prescribed (8%). Supply (48) and administration (75) incidents were reported less frequently. The audit demonstrated the very high frequency with which pharmacy staff identify and resolve insulin related prescribing safety incidents and the very low frequency with which this activity is reported. Patients on insulin appear to be at particularly high risk of prescribing incidents and this requires consideration in terms of prioritising pharmacy services for this patient group and developing additional robust safety strategies for times when ward pharmacy services are not available.

A multi-centre audit of insulin administration by community nurse teams is available here.

Archived August 2018– The content of this report has not been updated since May 2015 . Some information may be out of date and links to other documents or websites may not work.

Acute CareCommunity Health ServicesEndocrine system disordersMental HealthResearch and AuditsSystem Safety